Michael Cook

749 total citations
19 papers, 414 citations indexed

About

Michael Cook is a scholar working on Oncology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Cook has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 4 papers in Neurology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Cook's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Michael Cook is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Michael Cook collaborates with scholars based in United States, United Kingdom and Germany. Michael Cook's co-authors include Chul Kim, Michael B. Atkins, Matthew Blackburn, Neil J. Shah, Subha Madhavan, Anas Belouali, Kieron Dunleavy, Stephen V. Liu, Aiwu Ruth He and Geoffrey T. Gibney and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Cook

17 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Cook United States 8 266 57 56 55 53 19 414
Kenji Kurihara Japan 17 326 1.2× 99 1.7× 205 3.7× 57 1.0× 91 1.7× 56 785
Stefano Ricci Italy 16 273 1.0× 62 1.1× 180 3.2× 46 0.8× 22 0.4× 67 860
Ilona Urbárová Norway 9 235 0.9× 84 1.5× 16 0.3× 4 0.1× 79 1.5× 18 523
Masaki Nakamoto Japan 10 313 1.2× 23 0.4× 39 0.7× 33 0.6× 118 2.2× 23 687
Maria Pichler Austria 11 164 0.6× 78 1.4× 48 0.9× 11 0.2× 11 0.2× 28 427
Magdalena Witkowska Poland 13 158 0.6× 78 1.4× 135 2.4× 18 0.3× 75 1.4× 45 478
Chengcheng Fu China 16 373 1.4× 20 0.4× 60 1.1× 26 0.5× 126 2.4× 132 855
Bente Lund Denmark 16 452 1.7× 18 0.3× 79 1.4× 9 0.2× 63 1.2× 44 834
P. Pasanen Finland 14 193 0.7× 67 1.2× 12 0.2× 9 0.2× 23 0.4× 35 627
Scott A. Wallace United States 7 88 0.3× 30 0.5× 23 0.4× 5 0.1× 21 0.4× 19 347

Countries citing papers authored by Michael Cook

Since Specialization
Citations

This map shows the geographic impact of Michael Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cook more than expected).

Fields of papers citing papers by Michael Cook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cook. The network helps show where Michael Cook may publish in the future.

Co-authorship network of co-authors of Michael Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cook. A scholar is included among the top collaborators of Michael Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cook. Michael Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dave, Nikita, A Watts, Michael Cook, et al.. (2025). Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma. PubMed. 2(3). 100102–100102.
2.
Schneider, Michael, Elise A. Chong, Stefan K. Barta, et al.. (2024). Real-World Outcomes of Early Relapsed/Refractory Large B Cell Lymphoma Patients Treated with 2nd Line CAR T Therapy. Blood. 144(Supplement 1). 5123–5123.
3.
4.
5.
Cook, Michael, Kepher H. Makambi, Yutong Luo, et al.. (2022). Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients. Blood Advances. 7(1). 32–39. 61 indexed citations
6.
Cook, Michael & Kieron Dunleavy. (2022). Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies. Current Oncology Reports. 24(9). 1121–1131. 2 indexed citations
7.
Shah, Neil J., et al.. (2022). The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids. Journal of the National Comprehensive Cancer Network. 20(7). 800–807.e1. 14 indexed citations
8.
Cook, Michael, Katherine White, Sameer Desale, et al.. (2021). Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19. Clinical Lymphoma Myeloma & Leukemia. 22(7). e452–e458. 2 indexed citations
9.
Cook, Michael & Kieron Dunleavy. (2021). Optimizing outcomes in primary mediastinal B-Cell lymphoma: is R-CHOP enough?. Blood Advances. 5(19). 3873–3875. 1 indexed citations
10.
11.
Cook, Michael, Judith E. Karp, & Catherine Lai. (2021). The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?. SHILAP Revista de lepidopterología. 3(1). 301–313. 14 indexed citations
12.
Shah, Neil J., Matthew Blackburn, Michael Cook, et al.. (2019). Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection. Journal for ImmunoTherapy of Cancer. 7(1). 353–353. 83 indexed citations
13.
Cook, Michael & Chul Kim. (2019). Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer. JAMA Oncology. 5(7). 1049–1049. 150 indexed citations
14.
Shah, Neil J., Matthew Blackburn, Michael Cook, et al.. (2019). Abstract 3230: Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients with HIV, hepatitis B, or hepatitis C viral infections. Cancer Research. 79(13_Supplement). 3230–3230. 2 indexed citations
15.
Cook, Michael & Chul Kim. (2019). Quality Assessment of a Systematic Review for HIV Infection and Advanced-Stage Cancer—In Reply. JAMA Oncology. 5(9). 1370–1370. 1 indexed citations
16.
Shah, Neil J., Matthew Blackburn, Michael Cook, et al.. (2019). Real-world outcomes of underrepresented patient populations treated with immune checkpoint inhibitors (ICIs): African American descent, poor ECOG performance status, and chronic viral infections.. Journal of Clinical Oncology. 37(15_suppl). 2587–2587. 5 indexed citations
17.
Elmore, Aurora C., Erin L. McClymont, Henry Elderfield, et al.. (2015). Antarctic Intermediate Water properties since 400 ka recorded in infaunal ( Uvigerina peregrina ) and epifaunal ( Planulina wuellerstorfi ) benthic foraminifera. Earth and Planetary Science Letters. 428. 193–203. 25 indexed citations
18.
Sarnthein, Michael, Holger Gebhardt, Thorsten Kiefer, et al.. (2004). Mid Holocene origin of the sea-surface salinity low in the subarctic North Pacific. Quaternary Science Reviews. 23(20-22). 2089–2099. 30 indexed citations
19.
Cook, Michael, L. J. Mangum, Robert C. Millard, et al.. (1990). Hydrographic observations from the US/PRC Cooperative Program in the Western Equatorial Pacific Ocean, cruises 1-4. Woods Hole Oceanographic Institution eBooks. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Kurihara Breakdown of academic impact, for papers by Stefano Ricci Breakdown of academic impact, for papers by Ilona Urbárová Breakdown of academic impact, for papers by Masaki Nakamoto Breakdown of academic impact, for papers by Maria Pichler Breakdown of academic impact, for papers by Magdalena Witkowska Breakdown of academic impact, for papers by Chengcheng Fu Breakdown of academic impact, for papers by Bente Lund Breakdown of academic impact, for papers by P. Pasanen Breakdown of academic impact, for papers by Scott A. Wallace
Rankless by CCL
2026